Market Tracker

06/22 5:16pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

130.57
Delayed Data
As of 3:59pm ET
 +2.17 / +1.69%
Today’s Change
96.63
Today|||52-Week Range
177.93
+20.17%
Year-to-Date
Here Comes a Big Breakout For Alibaba
Jun 20 / TheStreet.com - Paid Partner Content
Intercept (ICPT) Down 3.5% Since Earnings Report: Can It Rebound?
Jun 12 / Zacks.com - Paid Partner Content
Intercept (ICPT) Releases Data from Phase II Flint Trial
Jun 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close128.40
Today’s open128.40
Day’s range127.43 - 131.97
Volume369,623
Average volume (3 months)395,788
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)-75.10%
Earnings growth (this year)+13.54%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+796.87%
P/E ratioNM
Price/Sales107.40
Price/Book10.12

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+1.63+1.96%
CBPOChina Biologic Produ...+0.17+0.15%
PBYIPuma Biotechnology I...+6.20+7.73%
IRWDIronwood Pharmaceuti...+0.17+0.87%
Data as of 3:59pm ET, 06/22/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$3.71
Annual revenue (last year)$25.0M
Annual profit (last year)-$412.8M
Net profit margin-1,654.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts